• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-丁基-N-(4-羟基丁基)亚硝胺诱发大鼠膀胱移行细胞癌发育过程中的转化阶段

Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats.

作者信息

Kunze E, Schauer A, Schatt S

出版信息

Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976;87(2):139-60. doi: 10.1007/BF00284372.

DOI:10.1007/BF00284372
PMID:136822
Abstract

The histogenesis of papillary and nonpapillary transitional cell carcinomas were studied morphologically and autoradiographically in 177 female Wistar rats after oral application of N-butyl-N-(4-hydroxybutyl)-nitrosamine with varying exposure and induction times. By far the largest proportion of carcinomas developed by a malignant transformation of preexisting papillomas or their precursors, the papillary hyperplasias. The transition into a focally malignant growth did not take place abruptly, but occurred stepwise through different successive stages of transformation, each having its own distinct morphological character. The first stage consisted of a focal, sharpely defined cellular atypia. In a further stage carcinomata in situ developed out of the atypical foci and progressed finally in a last stage of transformation into a circumscript infiltrative growth. The successive development of each stage occurred independent of any further carcinogen application after transformation was initiated at the molecular level. The number of papillomas with transformation stages increased with a lengthening of the exposure and induction time. 74.4% of all the registered papillomas had been transformed. Consequently papillomas must be considered potentially highly malignant. The 3H-TdR index was 4.2 times higher in atypical urothelial areas (7.6%) and 7.5 times higher in carcinomata in situ (14.3%) than in the surrounding papillomatous structures which appeared light microscopically benign. The latter demonstrated a rather constant 3H-TdR index, whether they bordered on atypical foci (1.8%) or carcinomata in situ (1.9%). The length of exposure and induction time exercised no significant influence on the degree of proliferative activity. The development of transitional cell carcinomas from a primary carcinoma in situ (intraurothelial carcinoma) played a much less significant role.

摘要

对177只雌性Wistar大鼠口服不同暴露时间和诱导时间的N-丁基-N-(4-羟丁基)-亚硝胺后,从形态学和放射自显影方面研究了乳头状和非乳头状移行细胞癌的组织发生。到目前为止,绝大多数癌是由先前存在的乳头状瘤或其前体即乳头状增生的恶性转化形成的。向局灶性恶性生长的转变并非突然发生,而是通过不同的连续转化阶段逐步进行的,每个阶段都有其独特的形态特征。第一阶段表现为局灶性、界限清楚的细胞异型性。在进一步的阶段,原位癌从非典型病灶发展而来,并最终在转化的最后阶段发展为局限性浸润性生长。在分子水平引发转化后,每个阶段的连续发展独立于任何进一步的致癌物应用。随着暴露和诱导时间的延长,具有转化阶段的乳头状瘤数量增加。所有登记的乳头状瘤中有74.4%发生了转化。因此,乳头状瘤必须被认为具有潜在的高度恶性。非典型尿路上皮区域的3H-TdR指数比光镜下看似良性的周围乳头状结构高4.2倍(7.6%),原位癌的3H-TdR指数比周围乳头状结构高7.5倍(14.3%)。后者的3H-TdR指数相当恒定,无论它们与非典型病灶(1.8%)还是原位癌(1.9%)相邻。暴露和诱导时间的长短对增殖活性程度没有显著影响。原位癌(尿路上皮内癌)发展为移行细胞癌所起的作用要小得多。

相似文献

1
Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats.N-丁基-N-(4-羟基丁基)亚硝胺诱发大鼠膀胱移行细胞癌发育过程中的转化阶段
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976;87(2):139-60. doi: 10.1007/BF00284372.
2
A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine.使用N-丁基-N-(4-羟基丁基)亚硝胺诱导雌性F344大鼠移行细胞癌的定量给药方案。
J Natl Cancer Inst. 1979 Jan;62(1):187-91.
3
Morphology, classification and histogenesis of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced carcinomas in the urinary bladder of rats.N-丁基-N-(4-羟丁基)亚硝胺诱导的大鼠膀胱癌的形态学、分类及组织发生学
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1977;88(3):273-89. doi: 10.1007/BF00305365.
4
Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.用N-丁基-N-(4-羟基丁基)亚硝胺、N-(4-(5-硝基-2-呋喃基)-2-噻唑基)甲酰胺、N-2-芴基乙酰胺和3,3'-二氯联苯胺处理的大鼠膀胱致癌的协同作用。
Gan. 1977 Apr;68(2):183-92.
5
E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.大鼠中由N-丁基-N-(4-羟基丁基)亚硝胺诱导的尿路上皮癌发生过程中E-钙黏蛋白的表达
J Exp Clin Cancer Res. 2006 Sep;25(3):425-32.
6
Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats.
Acta Pathol Jpn. 1982 Mar;32(2):243-50. doi: 10.1111/j.1440-1827.1982.tb02045.x.
7
Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.维生素A醋酸酯对N-丁基-N-(4-羟基丁基)亚硝胺诱导的大鼠膀胱致癌作用的影响。
Gan. 1978 Dec;69(6):845-8.
8
13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Science. 1977 Nov 18;198(4318):743-4. doi: 10.1126/science.910158.
9
Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.细胞周期蛋白D1在大鼠二阶段膀胱癌发生中的过表达及其与癌基因、肿瘤抑制基因和细胞增殖的关系。
Cancer Res. 1997 Nov 1;57(21):4765-76.
10
Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.N-丁基-N-(4-羟基丁基)亚硝胺、N-(4-(5-硝基-2-呋喃基)-2-噻唑基)甲酰胺、N-2-氟烯基乙酰胺和3,3'-二氯联苯胺对大鼠膀胱癌发生的联合作用
Gan. 1977 Apr;68(2):193-202.

引用本文的文献

1
Gene Expression and DNA Methylation Status of Glutathione S-Transferase Mu1 and Mu5 in Urothelial Carcinoma.尿路上皮癌中谷胱甘肽S-转移酶Mu1和Mu5的基因表达及DNA甲基化状态
PLoS One. 2016 Jul 12;11(7):e0159102. doi: 10.1371/journal.pone.0159102. eCollection 2016.
2
[Karyometry of BBN-induced precancerosis of the urothelium : An experimental analysis].
Urologe A. 2016 Oct;55(10):1329-1334. doi: 10.1007/s00120-016-0078-5.
3
DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urothelium.N-丁基-N-(4-羟丁基)亚硝胺诱导的膀胱尿路上皮癌前病变的DNA细胞光度学和组织学分析

本文引用的文献

1
The biological behavior of transitional cell papilloma of the bladder.膀胱移行细胞乳头状瘤的生物学行为
J Urol. 1950 May;63(5):815-20. doi: 10.1016/S0022-5347(17)68833-5.
2
Papillomas of the urinary bladder; survey and follow-up of 183 cases.膀胱乳头状瘤;183例病例的调查与随访
Acta Pathol Microbiol Scand Suppl (1926). 1955;105:118-34.
3
[SELECTIVE INDUCTION OF BLADDER CANCER IN RATS BY DIBUTYL- AND N-BUTYL-N-BUTANOL(4)-NITROSAMINE].[二丁基和 N-丁基-N-丁醇(4)-亚硝胺对大鼠膀胱癌的选择性诱导]
J Cancer Res Clin Oncol. 2016 Jun;142(6):1253-60. doi: 10.1007/s00432-016-2153-0. Epub 2016 Mar 31.
4
Induction of invasive transitional cell bladder carcinoma in immune intact human MUC1 transgenic mice: a model for immunotherapy development.在免疫健全的人MUC1转基因小鼠中诱导浸润性移行细胞膀胱癌:一种用于免疫治疗开发的模型。
J Vis Exp. 2013 Oct 30(80):e50868. doi: 10.3791/50868.
5
Omega-3 fatty acids inhibit tumor growth in a rat model of bladder cancer.ω-3 脂肪酸抑制膀胱癌大鼠模型中的肿瘤生长。
Biomed Res Int. 2013;2013:368178. doi: 10.1155/2013/368178. Epub 2013 Jun 20.
6
Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue.利用患者来源的肿瘤组织开发和表征膀胱癌异种移植模型。
Cancer Sci. 2013 May;104(5):631-8. doi: 10.1111/cas.12123. Epub 2013 Mar 24.
7
Biological similarities between murine chemical-induced and natural human bladder carcinogenesis.小鼠化学诱导的膀胱癌与人类自然发生的膀胱癌之间的生物学相似性。
Oncol Lett. 2010 Mar;1(2):373-377. doi: 10.3892/ol_00000066. Epub 2010 Mar 1.
8
Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties.阿托伐他汀对亚硝胺诱导的大鼠膀胱癌的化学预防作用:抗氧化、抗增殖和抗炎特性。
Int J Mol Sci. 2012;13(7):8482-8499. doi: 10.3390/ijms13078482. Epub 2012 Jul 9.
9
Exploring molecular genetics of bladder cancer: lessons learned from mouse models.探索膀胱癌的分子遗传学:从小鼠模型中获得的经验教训。
Dis Model Mech. 2012 May;5(3):323-32. doi: 10.1242/dmm.008888. Epub 2012 Mar 15.
10
Pathobiology and chemoprevention of bladder cancer.膀胱癌的病理生物学与化学预防。
J Oncol. 2011;2011:528353. doi: 10.1155/2011/528353. Epub 2011 Sep 15.
Z Krebsforsch. 1964 Nov 2;66:280-90.
4
ELECTRON MICROSCOPY AND TRITIATED THYMIDINE IN GRADATION OF MALIGNANCY OF HUMAN BLADDER CARCINOMAS.电子显微镜检查与氚标记胸腺嘧啶在人类膀胱癌恶性程度分级中的应用
J Urol. 1965 Feb;93:217-23. doi: 10.1016/S0022-5347(17)63749-2.
5
EXPERIMENTAL STUDIES ON THE BIOLOGICAL POTENTIAL OF BLADDER TUMORS.膀胱肿瘤生物学潜能的实验研究
J Urol. 1965 Feb;93:202-11. doi: 10.1016/S0022-5347(17)63747-9.
6
NATURAL HISTORY AND CLINICAL BEHAVIOR OF IN SITU CARCINOMA OF THE HUMAN URINARY BLADDER.人膀胱原位癌的自然史与临床行为
Cancer. 1964 Dec;17:1533-45. doi: 10.1002/1097-0142(196412)17:12<1533::aid-cncr2820171205>3.0.co;2-7.
7
THE CLINICAL COURSE OF 234 NEOPLASMS OF THE BLADDER IN NORTH-EAST SCOTLAND.苏格兰东北部234例膀胱肿瘤的临床病程
Br J Urol. 1964 Jun;36:204-10. doi: 10.1111/j.1464-410x.1964.tb09501.x.
8
[ON THE MORPHOLOGY OF BLADDER CANCER WITH SPECIAL REFERENCE TO ITS LOCAL SPREAD].[论膀胱癌的形态学,特别涉及其局部扩散]
Urologe. 1964 Mar;3:72-9.
9
REPORT OF A FOLLOW-UP OF PAPILLARY TUMOURS OF THE BLADDER.膀胱乳头状瘤随访报告
Br J Urol. 1964 Mar;36:14-25. doi: 10.1111/j.1464-410x.1964.tb09475.x.
10
INVERTED PAPILLOMA OF THE BLADDER.膀胱内翻性乳头状瘤
J Urol. 1963 Aug;90:175-9. doi: 10.1016/S0022-5347(17)64384-2.